←
Yen-Der Li36 posts
Yen-Der Li avatar

Yen-Der Li

@LiYender

Passionate about science, medicine, and business

◷ Joined May 2019
RTW Investments, LP avatar
⟳ Yen-Der Li retweeted
RTW Investments, LP@RtwLp·28 Aug 2025

RTW Investments recently hosted our RTW Intern Alumni Night! Current interns had the opportunity to relax, network, and hear from accomplished alums who shared their experiences and career insights.

Post attachmentPost attachmentPost attachmentPost attachment
Andrew Pannu avatar
⟳ Yen-Der Li retweeted
Andrew Pannu@andrewpannu·14 Feb 2023

Gene therapy landscape I pulled together 42 public companies and charted the preclinical & clinical assets of each, segmented by approach & vector Some takeaways:

Post attachment
Stephan Hacker (inactive account) avatar
⟳ Yen-Der Li retweeted
Stephan Hacker (inactive account)@StephanHacker2·26 Jan 2023

Great paper by the group of @georg_e_winter in @J_A_C_S. They establish a luciferase-based screening platform that allows the systematic identification of new E3 ligases amenable to molecular glue design as well as their degradation targets. doi.org/10.1021/jacs.2c10784

NH BAE avatar
⟳ Yen-Der Li retweeted
NH BAE@ghostbnh·14 Jan 2023

A very informative read! Protein–protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction Drs. Jaeki Min P. Ryan Potts, Ph.D. Congratulations! lnkd.in/gWFQidGw lnkd.in/gSPrKTHz

Hojong Yoon avatar
⟳ Yen-Der Li retweeted
Hojong Yoon@hojong_yoon·9 Dec 2022

I've always been somewhat skeptical about bifunctional modalities due to their "expected" poor PK/PD, but many molecules surprised me with their superior efficacy despite their bizarre shape, and now we got some clues - groundbreaking work from @kevansf science.org/doi/10.1126/scie…

Post attachment